Following the launch of its Wegovy (semaglutide) pill at the beginning of the year, Novo Nordisk is committing as much as ...
Men and women react differently to different drugs. That may sound like a no-brainer, but for years researchers have mainly focused on male patients’ reactions to drugs in clinical trials, which has ...
Blockchain is a database of information shared across a network. They're known in cryptocurrency systems like Bitcoin. Blockchain technology has the potential to revolutionize the drug discovery ...
KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the ...
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
A portable device that can instantly detect dangerous street drugs at extremely low concentrations has been developed at the University of Bath in the UK. The device, which is being trialled by ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The pharmaceutical industry faces the challenge of balancing innovation with affordability.
DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.
Over the past decade, glucagon-like peptide-1 receptor (GLP-1R) agonists have transformed the treatment of type 2 diabetes and obesity. Anti-diabetic drugs such as semaglutide and liraglutide not only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results